Bafna Pharmaceuticals Limited (BAFNAPH)

Volume: 67,584Avg Vol 1W: 1,05,009.2Avg Vol 1M: 28,791.652W Range:₹73.01₹213.36

₹165.45▼ 5.00%

Key Ratios

Market Cap—

Current Price₹165.45

Previous Close₹174.15

High / Low (52w)₹213.36 / ₹73.01

Volume67,584

Avg Vol (1W)1,05,009.2

Avg Vol (1M)28,791.6

Stock P/E142.63

Book Value₹40.64

Dividend Yield—

ROE—

ROA—

Revenue (TTM)₹149 Cr

Revenue Growth-2.6%

Profit Margin—

Total Debt₹3 Cr

Shares Outstanding—

Face Value₹10

EPS (TTM)₹1.16

P/B—

Debt / Equity—

50 DMA₹138.69

200 DMA₹135.91

Day change-5.00%

Price Chart

₹165.45▲ 117.75% · 1Y

2025-06-17

2026-06-12

20-day avg volume: 29K shares

Cons

Quarterly Results

Metric	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Revenue	₹33 Cr	₹40 Cr	₹33 Cr	₹39 Cr	₹35 Cr	₹35 Cr	₹38 Cr	₹42 Cr
EBITDA	₹0 Cr	₹3 Cr	₹2 Cr	₹4 Cr	₹4 Cr	₹4 Cr	₹3 Cr	₹4 Cr
Net Profit	₹-1 Cr	₹3 Cr	₹1 Cr	₹1 Cr	₹3 Cr	₹3 Cr	₹2 Cr	₹3 Cr
EPS	—	—	—	—	—	—	—	—

Profit & Loss (Annual)

Metric	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Revenue	₹43 Cr	₹72 Cr	₹87 Cr	₹119 Cr	₹156 Cr	₹149 Cr
EBITDA	₹-2 Cr	₹7 Cr	₹8 Cr	₹14 Cr	₹10 Cr	₹9 Cr
Net Profit	₹-25 Cr	₹6 Cr	₹5 Cr	₹11 Cr	₹7 Cr	₹4 Cr
EPS	—	—	—	—	—	—

Balance Sheet

Metric	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Total Assets	₹71 Cr	₹86 Cr	₹90 Cr	₹130 Cr	₹148 Cr	₹153 Cr
Total Liabilities	₹20 Cr	₹30 Cr	₹28 Cr	₹56 Cr	₹67 Cr	₹68 Cr
Equity	₹51 Cr	₹57 Cr	₹62 Cr	₹73 Cr	₹81 Cr	₹85 Cr
Total Debt	₹3 Cr	₹5 Cr	₹3 Cr	₹7 Cr	₹9 Cr	₹13 Cr

Cash Flow

Metric	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Operating	₹-34 Cr	₹-14 Cr	₹10 Cr	₹5 Cr	₹10 Cr	₹22 Cr
Investing	₹33 Cr	₹-5 Cr	₹-7 Cr	₹-7 Cr	₹-15 Cr	₹-21 Cr
Financing	₹7 Cr	₹12 Cr	₹-5 Cr	₹10 Cr	₹-1 Cr	₹1 Cr
Free Cash Flow	₹-34 Cr	₹-14 Cr	₹10 Cr	₹5 Cr	₹10 Cr	₹22 Cr

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search